Evaluating the real costs of drug therapy
Halpern, G.A.
American Journal of Hospital Pharmacy 46(12): 2460-2461
1989
ISSN/ISBN: 0002-9289 PMID: 2603875 Document Number: 344209
Document emailed within 1 workday
Related Documents
Kappeler, K.H.; Birdwell, S.W.; Scheckelhoff, D.J.; Reilly, C.H. 1992: Model for evaluating costs associated with I.v. drug delivery systems American Journal of Hospital Pharmacy 49(6): 1478-1481Jerome, D.; Laurent, C.; Catherine, B.; Didier, S.; Bertrand, C.; Muriel, R.; Joseph, M.; Olivier, Z.; Thiery, P.; Claude, C.J.an 2002: Costs of hospital management of hepatitis C virus cirrhosis in France Comparison between real costs and diagnosis related groups based costs Results of a multicentric study carried out on 267 consecutive patients in 1998 Hepatology 36(4 Part 2): 587A
Mössinger, F. 1993: Costs and financial feasibility of long-term drug therapy of chronic polyarthritis Zeitschrift für Rheumatologie 52(6): 409-412
Piatnitskaia, I.N.; Naĭdenova, N.G.; Goriushkin, I.I. 1983: Principles for evaluating reactivity in the clinical picture of alcoholism and addiction during drug therapy Zhurnal Nevropatologii i Psikhiatrii Imeni S.S. Korsakova 83(2): 243-249
Canafax, D.M.; Carleton, B.C.; Matas, A.J.; Payne, W.D.; Dunn, D.L.; Sutherland, D.E.; Najarian, J.S. 1993: Effects of three immunosuppressive drug protocols on cadaver renal transplantation costs after 4 years of therapy Transplantation Proceedings 25(1 Pt 2): 1692-1693
2012: Costs for traditional meds static while specialty drug costs soar Managed Care 21(6): 47
Dryden, M.W.; Carithers, D.; Murray, M.J. 2011: Flea control: real homes, real problems, real answers, real lessons: hitchhiker fleas and the indoor-only cats Compendium 33(6): E4
Stockamp, D.R. 2006: Revenue cycle outsourcing: the real costs and benefits Healthcare Financial Management: Journal of the Healthcare Financial Management Association 60(4): 84
Smucker, J.D. 2007: A reader and author respond to "Getting control of health costs - for real" MedGenMed: Medscape general medicine 9(4): 53; author reply 53
Kolacz, J.W. 1975: Methods of computing costs of prophylaxis and therapy of parasitic diseases in domestic animals: costs and cost analysis Wiadomosci Parazytologiczne 21(2): 329-338
Abourjaily, P.; Gouveia, W.A.; Selker, H.P.; Zucker, D.R. 2005: Evaluating the nondrug costs of formulary coverage restrictions Managed Care 14(8): 50-7 62
Rabøl, R.; Kolbye, A.; Andersen, S.Ejdrup. 2003: Drug costs in departments of internal medicine. An analysis of costs for patients and departments Ugeskrift for Laeger 165(15): 1565-1568
Luna, D.R.; Rizzato Lede, D.A.; Rubin, L.; Otero, C.M.; Ortiz, J.M.; García, Mónica.G.; Rapisarda, R.P.; Risk, M.R.; González Bernaldo de Quirós, Fán. 2017: User-Centered Design Improves the Usability of Drug-Drug Interaction Alerts: A Validation Study in the Real Scenario Studies in Health Technology and Informatics 245: 1085-1089
Lee, J. 2014: Assessing drug value. Hospitals take steps to control drug costs and aid patients Modern Healthcare 44(48): 22; 24-25
Yang, M.; Galebach, P.J.; Signorovitch, J.E.; Garg, V. 2017: Effectiveness and healthcare costs among stabilised rheumatoid arthritis patients with dose reduction of adalimumab or etanercept in real world Clinical and Experimental Rheumatology 35(5): 791-798
George, C.; Yesoda, A.; Jayakumar, B.; Lal, L. 2009: A prospective study evaluating clinical outcomes and costs of three NNRTI-based HAART regimens in Kerala, India Journal of Clinical Pharmacy and Therapeutics 34(1): 33-40
Andreasen, J. 2003: Increasing drug costs. The society's drug expenditures are strongly increasing. If this trend continues we have to make other priorities Ugeskrift for laeger 165(29): 2873-2876
Costa, J.R.; Sousa, A.; Moreira, A.C.; Costa, R.A.; Maldonado, G.; Cano, M.N.; Egito, E.T.; Romano, E.R.; Barbosa, M.; Pavanello, R.; Jardim, C.és.; Cury, A.ão.; Berwanger, O.áv.; Sousa, J.E. 2008: Drug-eluting stents in the elderly: long-term (> one year) clinical outcomes of octogenarians in the DESIRE (Drug-Eluting Stents in the REal world) registry Journal of Invasive Cardiology 20(8): 404-410
Andersen, V. 1993: Drug costs Ugeskrift for Laeger 155(42): 3398-3399
Lexchin, J. 1989: Reducing drug costs New Zealand Medical Journal 102(872): 387